CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001.
Collins SE, Jean Juste MA, Koenig SP, Secours R, Ocheretina O, Bernard D, Riviere C, Calnan M, Dunning A, Hurtado Rúa SM, Johnson WD Jr, Pape JW, Fitzgerald DW, Severe P.
Collins SE, et al. Among authors: ocheretina o.
Int J Tuberc Lung Dis. 2015 Jan;19(1):50-7. doi: 10.5588/ijtld.14.0217.
Int J Tuberc Lung Dis. 2015.
PMID: 25519790
Clinical Trial.